Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cyrille Orset has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Denis Vivien

    Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron

    9 shared publications
  • Arthur Chavignon

    Sorbonne Université, UMR 7371 CNRS, Inserm U1146, Laboratoire d’Imagerie Biomédicale, Paris, France

    2 shared publications
  • Carine Ali

    Normandie Univ, UNICAEN, INSERM, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders, Institut Blood and Brain @ Caen-Normandie, Cyceron, Caen, France

    2 shared publications
  • Gregory Dal Bo

    Department of Toxicology and Chemical Risks, French Armed Forces Biomedical Research Institute, Bretigny-sur-Orge, France; Laboratoire d'Imagerie Biomédicale Multimodale (BioMaps), CEA, CNRS, Inserm, Service Hospitalier Frédéric Joliot, Université Paris-Saclay, Orsay, France

    2 shared publications
  • Jonathane Furon

    Normandie University, UNICAEN, INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders (PhIND), GIP Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), Caen, France

    2 shared publications
  • Olivier Couture

    Sorbonne Université, UMR 7371 CNRS, Inserm U1146, Laboratoire d’Imagerie Biomédicale, Paris, France

    2 shared publications

Latest Publications

  • Inhibition of tPA-NMDAR interaction prevents neurovascular and functional deficits induced by organophosphorus nerve agents

    by Mélanie Lagadec, Karine Thibault, Jonathane Furon, Rosalie Bel, Denis Vivien, Gregory Dal Bo, Cyrille Orset

    Organophosphorus compounds (OP), including pesticides and nerve agents such as sarin, soman and Novichok, irreversibly inhibit cholinesterases (ChE), resulting in excessive cholinergic signaling, excitotoxicity, and neuroinflammation. Although current countermeasures provide partial protection, OP exposure remains associated with central nervous system (CNS) damage, including blood-brain barrier (BBB) disruption and cognitive impairments. In this study, we identify a critical role for tissue-type plasminogen activator (tPA)-a serine protease that modulates neuronal and endothelial N-methyl-D- aspartate receptor (NMDAR) signaling-in mediating OP-induced brain injury. Using a murine model exposed to soman or the nerve agent surrogate 4-nitrophenyl isopropylmethylphosphonate (NIMP), we show that OP exposure elevates circulating tPA levels, exacerbating neuroinflammation, BBB leakage, and neurovascular coupling impairment. Notably, blockade of the tPA-NMDAR interaction using Glunomab, a monoclonal antibody, prevents these effects. Our findings identify tPA-NMDAR signaling as a key mediator of OP-induced CNS damage and a promising therapeutic target.


  • Functional Ultrasound Imaging Uncovers Vascular Connectivity and Dynamics in Awake Mice During Hyperacute Stroke Phase

    by Myriam Abioui-Mourgues, Amandine Elodie Bonnet, Canelle C.M. Lepillier, Camille Brodin, Samuel Diebolt, Kaciel Béraud, Mickaël Tanter, Thomas Deffieux, Denis Vivien, Cyrille Orset

    BACKGROUND: Acute ischemic stroke models often rely on anesthesia, which alters neurovascular coupling and limits real-time functional assessment. We tested the hypothesis that an awake mouse model of thromboembolic stroke, combined with multimodal imaging, would reveal very early cerebrovascular dynamics and connectivity changes predictive of final lesion outcomes. METHODS: Male Swiss mice (6–8 weeks old; 30–40 g; n=60) were implanted with a cranial headplate and habituated to restraint and imaging. One microliter pneumatic injection of murine thrombin (1 IU) into the distal middle cerebral artery induced in situ clot formation. Twenty minutes postocclusion, mice received intravenous rtPA (recombinant tissue-type plasminogen activator; Alteplase, 10 mg/kg; 10% bolus/90% infusion over 40 minutes, n=31) or saline (n=29). Primary outcomes included lesion volume (T2-weighted magnetic resonance imaging at 24 hours), brain perfusion (ASL magnetic resonance imaging), cerebral blood volume variations (ultrafast Doppler US imaging), resting-state connectivity, and neurovascular coupling to whisker stimulation (functional ultrasound imaging). Sample size (n=12 per group for imaging) was based on prior variability. Statistical analyses included unpaired t tests, repeated-measures ANOVA with Dunnett or Tukey post hoc, and simple linear regression; significance set at P 3 in controls; t 58 =4.624; P P P =0.0024). CBV declined by 59.2±12.9% at 10 minutes and partially recovered with rtPA at 1 hour (+87.3±30.6%; P =0.0165). Early hypoperfused area (10 minutes) predicted final lesion observed at 24 hours ( R ²=0.6465; P =0.0016). Resting-state connectivity shift of 12.0° at 10 minutes was mitigated by rtPA by 1 hour (14.8° versus 3.6°; P P =0.0038) and showed partial recovery by 24 hours with rtPA (+37.2% relative to 10 minutes). At this time point, responses no longer differed significantly from baseline ( P =0.093), indicating a modest but functionally meaningful recovery despite marked interindividual variability. CONCLUSIONS: Awake thromboembolic stroke model with early functional ultrasound imaging completed with magnetic resonance imaging uncovers rapid blood flow perturbations and connectivity disruptions that are sensitive to rtPA and predictive of final lesion outcome. This platform enhances translational relevance by enabling hypothesis-testing of novel thrombolytics under physiologically intact conditions.


  • Open Access

    3D Transcranial ultrasound localization microscopy reveals major arteries in the sheep brain

    by Antoine Coudert, Louise Denis, Arthur Chavignon, Sylvain Bodard, Mikael Naveau, Palma Pro Sistiaga, Romaric Saulnier, Cyrille Orset, Denis Vivien, Christine Chappard, et al.

    Objective Stroke, a leading cause of mortality and disability globally, demands swift and accurate diagnosis for effective treatment. Although MRI and CT scans serve as conventional methods, their accessibility remains a challenge, prompting exploration into alternative, portable, and non-ionizing imaging solutions like ultrasound with reduced costs. While Ultrasound Localization Microscopy (ULM) displays potential in high-resolution vessel imaging, its 2D constraints limit its emergency utility. Materials and Methods This study delves into the feasibility of 3D ULM with multiplexed probe for transcranial vessel imaging in sheep brains, emulating human skull characteristics. Three sheep underwent 3D ULM imaging, compared with angiographic MRI, while skull characterization was conducted in vivo using ultrashort bone MRI sequences and ex vivo via micro CT. Results and conclusions The study showcased 3D ULM’s ability to highlight vessels, down to the Circle of Willis, yet within a confined 3D field-of-view. Future enhancements in signal, aberration correction, and human trials hold promise for a portable, volumetric, transcranial ultrasound angiography system. Summary statement 3D Ultrasound localization microscopy, using a low-frequency matrix probe, enables transcranial reconstruction of the main vessels in sheep brains.


  • Parabiosis Discriminates the Circulating, Endothelial, and Parenchymal Contributions of Endogenous Tissue-Type Plasminogen Activator to Stroke

    by Jonathane Furon, Florent Lebrun, Mervé Yétim, Damien Levard, Pauline Marie, Cyrille Orset, Sara Martinez de Lizarrondo, Denis Vivien, Carine Ali

    BACKGROUND: Intravenous injection of alteplase, a recombinant tPA (tissue-type plasminogen activator) as a thrombolytic agent has revolutionized ischemic stroke management. However, tPA is a more complex enzyme than expected, being for instance able to promote thrombolysis, but at the same time, also able to influence neuronal survival and to affect the integrity of the blood-brain barrier. Accordingly, the respective impact of endogenous tPA expressed/present in the brain parenchyma versus in the circulation during stroke remains debated. METHODS: To address this issue, we used mice with constitutive deletion of tPA (tPA Null [tPA-deficient mice]) or conditional deletion of endothelial tPA (VECad [vascular endothelial-Cadherin-Cre-recombinase]-Cre ∆tPA ). We also developed parabioses between tPA Null and wild-type mice (tPA WT ), anticipating that a tPA WT donor would restore levels of tPA to normal ones, in the circulation but not in the brain parenchyma of a tPA Null recipient. Stroke outcomes were investigated by magnetic resonance imaging in a thrombo-embolic or a thrombotic stroke model, induced by local thrombin injection or FeCl 3 application on the endothelium, respectively. RESULTS: First, our data show that endothelial tPA, released into the circulation after stroke onset, plays an overall beneficial role following thrombo-embolic stroke. Accordingly, after 24 hours, tPA Null /tPA Null parabionts displayed less spontaneous recanalization and reperfusion and larger infarcts compared with tPA WT /tPA WT littermates. However, when associated to tPA WT littermates, tPA Null mice had similar perfusion deficits, but less severe brain infarcts. In the thrombotic stroke model, homo- and hetero-typic parabionts did not differ in the extent of brain damages and did not differentially recanalize and reperfuse. CONCLUSIONS: Together, our data reveal that during thromboembolic stroke, endogenous circulating tPA from endothelial cells sustains a spontaneous recanalization and reperfusion of the tissue, thus, limiting the extension of ischemic lesions. In this context, the impact of endogenous parenchymal tPA is limited.


  • Open Access

    Long-Term Anxiety-like Behavior and Microbiota Changes Induced in Mice by Sublethal Doses of Acute Sarin Surrogate Exposure

    by Sabine François, Stanislas Mondot, Quentin Gerard, Rosalie Bel, Julie Knoertzer, Asma Berriche, Sophie Cavallero, Rachid Baati, Cyrille Orset, Gregory Dal Bo, et al.

    Anxiety disorder is one of the most reported complications following organophosphorus (OP) nerve agent (NA) exposure. The goal of this study was to characterize the long-term behavioral impact of a single low dose exposure to 4-nitrophenyl isopropyl methylphosphonate (NIMP), a sarin surrogate. We chose two different sublethal doses of NIMP, each corresponding to a fraction of the median lethal dose (one mild and one convulsive), and evaluated behavioral changes over a 6-month period following exposure. Mice exposed to both doses showed anxious behavior which persisted for six-months post-exposure. A longitudinal magnetic resonance imaging examination did not reveal any anatomical changes in the amygdala throughout the 6-month period. While no cholinesterase activity change or neuroinflammation could be observed at the latest timepoint in the amygdala of NIMP-exposed mice, important modifications in white blood cell counts were noted, reflecting a perturbation of the systemic immune system. Furthermore, intestinal inflammation and microbiota changes were observed at 6-months in NIMP-exposed animals regardless of the dose received. This is the first study to identify long-term behavioral impairment, systemic homeostasis disorganization and gut microbiota alterations following OP sublethal exposure. Our findings highlight the importance of long-term care for victims of NA exposure, even in asymptomatic cases.


  • Open Access

    The GHB analogue HOCPCA improves sensorimotor function after MCAO via CaMKIIα

    by Nane Griem-Krey, Anders B Klein, Bettina H Clausen, Mathias Rj Namini, Pernille V Nielsen, Heung-Chin Cheng, Cyrille Orset, Denis Vivien, Andrew N Clarkson, Kate L Lambertsen, et al.

    Ca 2+ /calmodulin-dependent protein kinase II alpha (CaMKIIα) is a major contributor to physiological and pathological glutamate-mediated Ca 2+ signals, and its involvement in various critical cellular pathways demands specific pharmacological strategies. We recently presented GHB ligands as the first small molecules selectively targeting the CaMKIIα hub, a domain primarily responsible for holoenzyme oligomerisation, with an emerging functional role. Here, we report that the GHB ligand, HOCPCA, improves sensorimotor function after experimental stroke in mice when administered at clinically relevant time and in combination with alteplase. We observed that hub modulation by HOCPCA results in differential effects on distinct CaMKII pools, ultimately alleviating aberrant CaMKII signalling after cerebral ischemia. As such, HOCPCA normalised cytosolic Thr286 autophosphorylation after ischemia in mice and downregulated the ischemia-specific expression of a constitutively active CaMKII kinase fragment. Previous studies suggest holoenzyme stabilisation as a potential mechanism, yet a causal link to in vivo findings requires further studies. HOCPCA’s selectivity and absence of effects on physiological CaMKII signalling highlight pharmacological modulation of the CaMKIIα hub domain as an attractive neuroprotective strategy.


  • Top Cited Papers
    Open Access

    3D Transcranial Ultrasound Localization Microscopy in the Rat Brain With a Multiplexed Matrix Probe

    by Arthur Chavignon, Baptiste Heiles, Vincent Hingot, Cyrille Orset, Denis Vivien, Olivier Couture

    Objective: Ultrasound Localization Microscopy (ULM) provides images of the microcirculation in-depth in living tissue. However, its implementation in two-dimension is limited by the elevation projection and tedious plane-by-plane acquisition. Volumetric ULM alleviates these issues and can map the vasculature of entire organs in one acquisition with isotropic resolution. However, its optimal implementation requires many independent acquisition channels, leading to complex custom hardware. Methods: In this article, we implemented volumetric ultrasound imaging with a multiplexed 32 × 32 probe driven by a single commercial ultrasound scanner. We propose and compare three different sub-aperture multiplexing combinations for localization microscopy in silico and in vitro with a flow of microbubbles in a canal. Finally, we evaluate the approach for micro-angiography of the rat brain. The “light” combination allows a higher maximal volume rate than the “full” combination while maintaining the field of view and resolution. Results : In the rat brain, 100,000 volumes were acquired within 7 min with a dedicated ultrasound sequence and revealed vessels down to 31 μm in diameter with flows from 4.3 mm/s to 28.4 mm/s. Conclusion : This work demonstrates the ability to perform a complete angiography with unprecedented resolution in the living rat's brain with a simple and light setup through the intact skull. Significance : We foresee that it might contribute to democratize 3D ULM for both preclinical and clinical studies.


  • Neonatal cerebral hypoxia-ischemia in mice triggers age-dependent vascular effects and disabilities in adults; implication of tissue plasminogen activator (tPA)

    by Nicolas Dupré, Arnaud Arabo, Cyrille Orset, Julie Maucotel, Yannick Detroussel, Michelle Hauchecorne, Bruno J. Gonzalez, Stéphane Marret, Denis Vivien, Philippe Leroux


  • Mouse Model of In Situ Thromboembolic Stroke and Reperfusion

    by Orset Cyrille, Le Béhot Audrey, Bonnet Anne-Laure, Maysami Samaneh, Vivien Denis


  • Open Access

    Plasminogen in cerebrospinal fluid originates from circulating blood

    by Anna Mezzapesa, Cyrille Orset, Laurent Plawinski, Loic Doeuvre, Sara Martinez de Lizarrondo, Guglielmina Chimienti, Denis Vivien, Alexandre Mansour, Sabrina Matà, Gabriella Pepe, et al.

    Plasminogen activation is a ubiquitous source of fibrinolytic and proteolytic activity. Besides its role in prevention of thrombosis, plasminogen is involved in inflammatory reactions in the central nervous system. Plasminogen has been detected in the cerebrospinal fluid (CSF) of patients with inflammatory diseases; however, its origin remains controversial, as the blood-CSF barrier may restrict its diffusion from blood. We investigated the origin of plasminogen in CSF using Alexa Fluor 488-labelled rat plasminogen injected into rats with systemic inflammation and blood-CSF barrier dysfunction provoked by lipopolysaccharide (LPS). Near-infrared fluorescence imaging and immunohistochemistry fluorescence microscopy were used to identify plasminogen in brain structures, its concentration and functionality were determined by Western blotting and a chromogenic substrate assay, respectively. In parallel, plasminogen was investigated in CSF from patients with Guillain-Barré syndrome (n = 15), multiple sclerosis (n = 19) and noninflammatory neurological diseases (n = 8). Endogenous rat plasminogen was detected in higher amounts in the CSF and urine of LPS-treated animals as compared to controls. In LPS-primed rats, circulating Alexa Fluor 488-labelled rat plasminogen was abundantly localized in the choroid plexus, CSF and urine. Plasminogen in human CSF was higher in Guillain-Barré syndrome (median = 1.28 ng/μl (interquartile range (IQR) = 0.66 to 1.59)) as compared to multiple sclerosis (median = 0.3 ng/μl (IQR = 0.16 to 0.61)) and to noninflammatory neurological diseases (median = 0.27 ng/μl (IQR = 0.18 to 0.35)). Our findings demonstrate that plasminogen is transported from circulating blood into the CSF of rats via the choroid plexus during inflammation. Our data suggest that a similar mechanism may explain the high CSF concentrations of plasminogen detected in patients with inflammation-derived CSF barrier impairment.